Paula L. Moreira

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease.

Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease.

Journal: Journal of Crohn's & colitis

Published: March 27, 2026

Baseline Sleep Literacy, Habits, and Perceptions Among Primary School Children: Foundations for a MAIEC-Guided Community Intervention in Sleep and Mental Health.

Baseline Sleep Literacy, Habits, and Perceptions Among Primary School Children: Foundations for a MAIEC-Guided Community Intervention in Sleep and Mental Health.

Journal: Healthcare (Basel, Switzerland)

Published: December 31, 2025

Establishing a multiple outcome set for Crohn's disease in real-world evidence studies: results from a Delphi e-survey.

Establishing a multiple outcome set for Crohn's disease in real-world evidence studies: results from a Delphi e-survey.

Journal: Journal of Crohn's & colitis

Published: November 09, 2025

Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework.

Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework.

Journal: United European gastroenterology journal

Published: July 01, 2024

Network Meta-Analysis: Histologic and Histo-Endoscopic Improvement and Remission With Advanced Therapy in Ulcerative Colitis.

Network Meta-Analysis: Histologic and Histo-Endoscopic Improvement and Remission With Advanced Therapy in Ulcerative Colitis.

Journal: Alimentary pharmacology & therapeutics

Published: June 16, 2024

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study.

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study.

Journal: European journal of clinical investigation

Published: April 24, 2024

The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients.

The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients.

Journal: Journal of Crohn's & colitis

Published: October 24, 2023

How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study.

How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study.

Journal: United European gastroenterology journal

Published: January 07, 2023

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta-analysis.

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta-analysis.

Journal: United European gastroenterology journal

Published: October 05, 2022

Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis.

Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis.

Journal: Inflammatory bowel diseases

Published: June 14, 2022

Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysis.

Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysis.

Journal: United European gastroenterology journal

Published: September 25, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026